A generic alternative indicated for pain relief. Reduction of uric acid production facilitates the management of inflammation arising from metabolic crystals.
A xanthine oxidase inhibitor utilized to manage chronic gout and intended to alleviate the formation of uric acid stones to support kidney health.
Mechanism of Action
It inhibits the enzyme xanthine oxidase, which is responsible for the production of uric acid. Lowering uric acid levels prevents the formation of painful crystals.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Allergy to allopurinol, Severe kidney disease (dosage adjustment needed)
Severe Adverse Events
Severe life-threatening rash (SJS), Liver failure, Severe allergic hypersensitivity, Bone marrow suppression
Information for Allopurinol is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
